Rational Design and In-Silico Evaluation of a Multi-Epitope Vaccine Targeting Human Glypican-3 (GPC3) for Hepatocellular Carcinoma Immunotherapy. Vascular and Endovascular Review, [S. l.], v. 8, n. 10s, p. 203–216, 2025. Disponível em: https://verjournal.com/index.php/ver/article/view/812. Acesso em: 8 apr. 2026.